Recent advances in the detection of ovarian cancer: A review
Epithelial ovarian cancer is one of the more aggressive malignancies among American women today, and its incidence is increasing. The major obstacle in combatting ovarian cancer is the remarkable lack of symptoms in early-stage disease. Symptoms usually occur in advanced stages when tumor disseminat...
Gespeichert in:
Veröffentlicht in: | Journal of Osteopathic Medicine (Online) 1994-04, Vol.94 (4), p.305-305 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 305 |
---|---|
container_issue | 4 |
container_start_page | 305 |
container_title | Journal of Osteopathic Medicine (Online) |
container_volume | 94 |
creator | Blend, Michael J. Ostrowski, Gregory J. |
description | Epithelial ovarian cancer is one of the more aggressive malignancies among American women today, and its incidence is increasing. The major obstacle in combatting ovarian cancer is the remarkable lack of symptoms in early-stage disease. Symptoms usually occur in advanced stages when tumor dissemination within the peritoneal cavity induces ascites with resultant increasing abdominal girth. Physicians have been unable to reach women who have early-stage ovarian cancer, a time when a high cure rate could be expected. However, during the past few years, significant developments in the areas of serum tumor markers, transvaginal ultrasonography with color flow Doppler analysis, immunodiagnostic techniques, and immunotherapy have been reported. These new modalities show promise for use in the early diagnosis and treatment of ovarian cancer. The authors review some of the new data and discuss patient outcomes when these new modalities are used. |
doi_str_mv | 10.7556/jaoa.1994.94.4.305 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76589720</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76589720</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2515-229d143a63cfadd8ae6cc86ea502d94ab458838c9a1ad93cd59597a04d34901c3</originalsourceid><addsrcrecordid>eNp9kFtLAzEQhYMoWqp_QBDy5NvWXHcT8UEp3kAQRJ_DmEx1S7tbk92W_nuztPgoDMzAnDmH-Qg552xSaV1ezaGFCbdWTXKpiWT6gIxExUQhS2UOyYgxa4qSa35CzlKaM8aE5lIIfkyODROltXZEbt7QY9NRCGtoPCZaN7T7RhqwQ9_VbUPbGW3XEGtoqB8k8Zre0YjrGjen5GgGi4Rn-z4mHw_379On4uX18Xl691L4nKgLIWzgSkIp_QxCMICl96ZE0EwEq-BTaWOk8RY4BCt90FbbCpgKUlnGvRyTy53vKrY_PabOLevkcbGABts-uarUxlaCZaHYCX1sU4o4c6tYLyFuHWduoOYGam6g5nIpl6nlo4u9e_-5xPB3smeU97e7_QYWHcaAX7Hf5sHN2z42-e9_zK1SQ8Qv26h8tw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76589720</pqid></control><display><type>article</type><title>Recent advances in the detection of ovarian cancer: A review</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Blend, Michael J. ; Ostrowski, Gregory J.</creator><creatorcontrib>Blend, Michael J. ; Ostrowski, Gregory J.</creatorcontrib><description>Epithelial ovarian cancer is one of the more aggressive malignancies among American women today, and its incidence is increasing. The major obstacle in combatting ovarian cancer is the remarkable lack of symptoms in early-stage disease. Symptoms usually occur in advanced stages when tumor dissemination within the peritoneal cavity induces ascites with resultant increasing abdominal girth. Physicians have been unable to reach women who have early-stage ovarian cancer, a time when a high cure rate could be expected. However, during the past few years, significant developments in the areas of serum tumor markers, transvaginal ultrasonography with color flow Doppler analysis, immunodiagnostic techniques, and immunotherapy have been reported. These new modalities show promise for use in the early diagnosis and treatment of ovarian cancer. The authors review some of the new data and discuss patient outcomes when these new modalities are used.</description><identifier>ISSN: 0098-6151</identifier><identifier>ISSN: 2702-3648</identifier><identifier>EISSN: 2702-3648</identifier><identifier>DOI: 10.7556/jaoa.1994.94.4.305</identifier><identifier>PMID: 8026999</identifier><language>eng</language><publisher>United States: American Osteopathic Association</publisher><subject>Antibodies, Monoclonal ; Biomarkers, Tumor - blood ; Diet ; Family Health ; Female ; Humans ; Magnetic Resonance Imaging ; Mass Screening ; Neoplasm Staging ; Ovarian Neoplasms - diagnosis ; Ovarian Neoplasms - etiology ; Ovarian Neoplasms - mortality ; Ovarian Neoplasms - therapy ; Physical Examination ; Prognosis ; Radioimmunodetection ; Risk Factors ; Survival Rate ; Tomography, X-Ray Computed</subject><ispartof>Journal of Osteopathic Medicine (Online), 1994-04, Vol.94 (4), p.305-305</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8026999$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Blend, Michael J.</creatorcontrib><creatorcontrib>Ostrowski, Gregory J.</creatorcontrib><title>Recent advances in the detection of ovarian cancer: A review</title><title>Journal of Osteopathic Medicine (Online)</title><addtitle>J Am Osteopath Assoc</addtitle><description>Epithelial ovarian cancer is one of the more aggressive malignancies among American women today, and its incidence is increasing. The major obstacle in combatting ovarian cancer is the remarkable lack of symptoms in early-stage disease. Symptoms usually occur in advanced stages when tumor dissemination within the peritoneal cavity induces ascites with resultant increasing abdominal girth. Physicians have been unable to reach women who have early-stage ovarian cancer, a time when a high cure rate could be expected. However, during the past few years, significant developments in the areas of serum tumor markers, transvaginal ultrasonography with color flow Doppler analysis, immunodiagnostic techniques, and immunotherapy have been reported. These new modalities show promise for use in the early diagnosis and treatment of ovarian cancer. The authors review some of the new data and discuss patient outcomes when these new modalities are used.</description><subject>Antibodies, Monoclonal</subject><subject>Biomarkers, Tumor - blood</subject><subject>Diet</subject><subject>Family Health</subject><subject>Female</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Mass Screening</subject><subject>Neoplasm Staging</subject><subject>Ovarian Neoplasms - diagnosis</subject><subject>Ovarian Neoplasms - etiology</subject><subject>Ovarian Neoplasms - mortality</subject><subject>Ovarian Neoplasms - therapy</subject><subject>Physical Examination</subject><subject>Prognosis</subject><subject>Radioimmunodetection</subject><subject>Risk Factors</subject><subject>Survival Rate</subject><subject>Tomography, X-Ray Computed</subject><issn>0098-6151</issn><issn>2702-3648</issn><issn>2702-3648</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kFtLAzEQhYMoWqp_QBDy5NvWXHcT8UEp3kAQRJ_DmEx1S7tbk92W_nuztPgoDMzAnDmH-Qg552xSaV1ezaGFCbdWTXKpiWT6gIxExUQhS2UOyYgxa4qSa35CzlKaM8aE5lIIfkyODROltXZEbt7QY9NRCGtoPCZaN7T7RhqwQ9_VbUPbGW3XEGtoqB8k8Zre0YjrGjen5GgGi4Rn-z4mHw_379On4uX18Xl691L4nKgLIWzgSkIp_QxCMICl96ZE0EwEq-BTaWOk8RY4BCt90FbbCpgKUlnGvRyTy53vKrY_PabOLevkcbGABts-uarUxlaCZaHYCX1sU4o4c6tYLyFuHWduoOYGam6g5nIpl6nlo4u9e_-5xPB3smeU97e7_QYWHcaAX7Hf5sHN2z42-e9_zK1SQ8Qv26h8tw</recordid><startdate>19940401</startdate><enddate>19940401</enddate><creator>Blend, Michael J.</creator><creator>Ostrowski, Gregory J.</creator><general>American Osteopathic Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19940401</creationdate><title>Recent advances in the detection of ovarian cancer: A review</title><author>Blend, Michael J. ; Ostrowski, Gregory J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2515-229d143a63cfadd8ae6cc86ea502d94ab458838c9a1ad93cd59597a04d34901c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Antibodies, Monoclonal</topic><topic>Biomarkers, Tumor - blood</topic><topic>Diet</topic><topic>Family Health</topic><topic>Female</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Mass Screening</topic><topic>Neoplasm Staging</topic><topic>Ovarian Neoplasms - diagnosis</topic><topic>Ovarian Neoplasms - etiology</topic><topic>Ovarian Neoplasms - mortality</topic><topic>Ovarian Neoplasms - therapy</topic><topic>Physical Examination</topic><topic>Prognosis</topic><topic>Radioimmunodetection</topic><topic>Risk Factors</topic><topic>Survival Rate</topic><topic>Tomography, X-Ray Computed</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Blend, Michael J.</creatorcontrib><creatorcontrib>Ostrowski, Gregory J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Osteopathic Medicine (Online)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Blend, Michael J.</au><au>Ostrowski, Gregory J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recent advances in the detection of ovarian cancer: A review</atitle><jtitle>Journal of Osteopathic Medicine (Online)</jtitle><addtitle>J Am Osteopath Assoc</addtitle><date>1994-04-01</date><risdate>1994</risdate><volume>94</volume><issue>4</issue><spage>305</spage><epage>305</epage><pages>305-305</pages><issn>0098-6151</issn><issn>2702-3648</issn><eissn>2702-3648</eissn><abstract>Epithelial ovarian cancer is one of the more aggressive malignancies among American women today, and its incidence is increasing. The major obstacle in combatting ovarian cancer is the remarkable lack of symptoms in early-stage disease. Symptoms usually occur in advanced stages when tumor dissemination within the peritoneal cavity induces ascites with resultant increasing abdominal girth. Physicians have been unable to reach women who have early-stage ovarian cancer, a time when a high cure rate could be expected. However, during the past few years, significant developments in the areas of serum tumor markers, transvaginal ultrasonography with color flow Doppler analysis, immunodiagnostic techniques, and immunotherapy have been reported. These new modalities show promise for use in the early diagnosis and treatment of ovarian cancer. The authors review some of the new data and discuss patient outcomes when these new modalities are used.</abstract><cop>United States</cop><pub>American Osteopathic Association</pub><pmid>8026999</pmid><doi>10.7556/jaoa.1994.94.4.305</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0098-6151 |
ispartof | Journal of Osteopathic Medicine (Online), 1994-04, Vol.94 (4), p.305-305 |
issn | 0098-6151 2702-3648 2702-3648 |
language | eng |
recordid | cdi_proquest_miscellaneous_76589720 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Antibodies, Monoclonal Biomarkers, Tumor - blood Diet Family Health Female Humans Magnetic Resonance Imaging Mass Screening Neoplasm Staging Ovarian Neoplasms - diagnosis Ovarian Neoplasms - etiology Ovarian Neoplasms - mortality Ovarian Neoplasms - therapy Physical Examination Prognosis Radioimmunodetection Risk Factors Survival Rate Tomography, X-Ray Computed |
title | Recent advances in the detection of ovarian cancer: A review |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T17%3A46%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recent%20advances%20in%20the%20detection%20of%20ovarian%20cancer:%20A%20review&rft.jtitle=Journal%20of%20Osteopathic%20Medicine%20(Online)&rft.au=Blend,%20Michael%20J.&rft.date=1994-04-01&rft.volume=94&rft.issue=4&rft.spage=305&rft.epage=305&rft.pages=305-305&rft.issn=0098-6151&rft.eissn=2702-3648&rft_id=info:doi/10.7556/jaoa.1994.94.4.305&rft_dat=%3Cproquest_cross%3E76589720%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76589720&rft_id=info:pmid/8026999&rfr_iscdi=true |